Actively Recruiting
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
Led by Second Affiliated Hospital of Guangxi Medical University · Updated on 2025-12-24
348
Participants Needed
38
Research Sites
100 weeks
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital of Guangxi Medical University
Lead Sponsor
G
Ganzhou City People's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess the safety and efficacy of early administration of tirofiban in patients treated with tenecteplase for acute ischemic stroke.
CONDITIONS
Official Title
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Received intravenous tenecteplase for acute ischemic stroke within the past 4-24 hours
- No significant symptom change compared to baseline (increase or decrease of 0 or 1 point in NIHSS score) or mild neurological deterioration (increase of 2 points or more in NIHSS score)
- NIHSS score of 4 or higher before randomization
- Patient or family has signed informed consent
You will not qualify if you...
- Intracranial hemorrhage confirmed by CT or MRI after thrombolysis and before randomization
- Occlusion in specific brain arteries shown by CTA/MRA/DSA imaging
- Confirmed or suspected cardioembolic stroke sources including atrial fibrillation, mitral stenosis, prosthetic heart valves, endocarditis, intracardiac thrombus, dilated cardiomyopathy, or high-risk embolic sources
- Platelet count below 100 x 10^9/L
- Severe kidney insufficiency with glomerular filtration rate below 30 mL/min
- Pregnant or breastfeeding women
- Allergy to tirofiban, nickel, titanium, or related alloys
- Neurological or psychiatric illness preventing assessment
- Pre-existing bleeding disorders or severe heart, liver, kidney disease, or sepsis
- Brain tumors causing space-occupying effects (except micromeningiomas)
- Intracranial aneurysm or arteriovenous malformation
- Life expectancy under 6 months due to advanced disease
- Participation in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 38 locations
1
Mingguang People's Hospital
Chuzhou, Anhui, China
Actively Recruiting
2
Longyan People´s Hospital, Longyan City
Longyan, Fujian, China
Actively Recruiting
3
The Second Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Actively Recruiting
4
Huangmei People's Hospital
Huanggang, Hubei, China
Actively Recruiting
5
Yiling People's Hospital of Yichang city
Yichang, Hubei, China
Actively Recruiting
6
Hunan Xupu Chengnan Hospital
Huaihua, Hunan, China
Actively Recruiting
7
People's Hospital Of Shaodong
Shaoyang, Hunan, China
Actively Recruiting
8
Shaoshan People's Hospital
Xiangtan, Hunan, China
Actively Recruiting
9
Xiangtan Central Hospitall
Xiangtan, Hunan, China
Actively Recruiting
10
Hunan University of Medicine Affiliated Pingjiang Hospital
Yueyang, Hunan, China
Actively Recruiting
11
Ganzhou People's Hospital
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
12
People's Hospital of Dayu County
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
13
People's Hospital of Ganxian District
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
14
People's Hospital of Quannan County
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
15
People's Hospital of RuiJin City
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
16
People's Hospital of Shangyou County
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
17
People's Hospital of Xinfeng County
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
18
People's Hospital of Xunwu County
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
19
People's Hospital of Yudu County
Ganzhou, Jiangxi, China, 341000
Actively Recruiting
20
Ganzhou Municipal Hospital
Ganzhou, Jiangxi, China
Actively Recruiting
21
Nankang TCM Hospital
Ganzhou, Jiangxi, China
Actively Recruiting
22
People's Hospital of Anyuan County
Ganzhou, Jiangxi, China
Actively Recruiting
23
People's Hospital of Chongyi County
Ganzhou, Jiangxi, China
Actively Recruiting
24
People's Hospital of Shicheng County
Ganzhou, Jiangxi, China
Actively Recruiting
25
Second Hospital of Xingguo County
Ganzhou, Jiangxi, China
Actively Recruiting
26
Second People's Hospital of Yudu County
Ganzhou, Jiangxi, China
Actively Recruiting
27
The People's Hospital of Ningdu County
Ganzhou, Jiangxi, China
Actively Recruiting
28
Traditional Chinese Medicine Hospital of Xingguo County
Ganzhou, Jiangxi, China
Actively Recruiting
29
Traditional Chinese Medicine Hospital of Yudu County
Ganzhou, Jiangxi, China
Actively Recruiting
30
Affiliated Hospital of Jiujiang University
Jiujiang, Jiangxi, China
Actively Recruiting
31
Ji'an Central People's Hospital
Ji’an, Jiangxi, China
Actively Recruiting
32
People's Hospital of Wan'an county
Ji’an, Jiangxi, China
Actively Recruiting
33
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Actively Recruiting
34
People's Hospital of Yichun
Yichun, Jiangxi, China
Actively Recruiting
35
Yingtan People's Hospital
Yingtan, Jiangxi, China
Actively Recruiting
36
Songyuan Jilin Oilfield Hospital
Songyuan, Jilin, China
Actively Recruiting
37
Dalian Municipal Central Hospital
Dalian, Liaoning, China
Actively Recruiting
38
Zhongmeng Hospital of Hexigten Banner
Chifeng, Neimenggu, China
Actively Recruiting
Research Team
D
Deyan Kong, MD
CONTACT
G
Guoyong Zeng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here